Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System

Key Takeaways Microbot won FDA 510(k) clearance for its LIBERTY Endovascular Robotic System.MBOT shares jumped 22.9% after the announcement and are up 301.8% year to date.The LIBERTY system is compact, disposable, and showed 100% navigation success in trials.Microbot Medical Inc. (MBOT) recently received FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, marking a major regulatory milestone for the company. The LIBERTY system is designed to provide physicians with improved control and precisi ...